Skip to main content

Exploring the impact of population ageing on the spread of emerging respiratory infections and the associated burden of mortality

Abstract

Background

Increasing life expectancy and persistently low fertility levels have led to old population age structures in most high-income countries, and population ageing is expected to continue or even accelerate in the coming decades. While older adults on average have few interactions that potentially could lead to disease transmission, their morbidity and mortality due to infectious diseases, respiratory infections in particular, remain substantial. We aim to explore how population ageing affects the future transmission dynamics and mortality burden of emerging respiratory infections.

Methods

Using longitudinal individual-level data from population registers, we model the Belgian population with evolving age and household structures, and explicitly consider long-term care facilities (LTCFs). Three scenarios are presented for the future proportion of older adults living in LTCFs. For each demographic scenario, we simulate outbreaks of SARS-CoV-2 and a novel influenza A virus in 2020, 2030, 2040 and 2050 and distinguish between household and community transmission. We estimate attack rates by age and household size/type, as well as disease-related deaths and the associated quality-adjusted life-years (QALYs) lost.

Results

As the population is ageing, small households and LTCFs become more prevalent. Additionally, families with children become smaller (i.e. low fertility, single-parent families). The overall attack rate slightly decreases as the population is ageing, but to a larger degree for influenza than for SARS-CoV-2 due to differential age-specific attack rates. Nevertheless, the number of deaths and QALY losses per 1,000 people is increasing for both infections and at a speed influenced by the share living in LTCFs.

Conclusion

Population ageing is associated with smaller outbreaks of COVID-19 and influenza, but at the same time it is causing a substantially larger burden of mortality, even if the proportion of LTCF residents were to decrease. These relationships are influenced by age patterns in epidemiological parameters. Not only the shift in the age distribution, but also the induced changes in the household structures are important to consider when assessing the potential impact of population ageing on the transmission and burden of emerging respiratory infections.

Peer Review reports

Background

The population age structures in most high-income countries have for decades been shifting towards older ages (i.e. population ageing) as a result of increasing life expectancy and persistent below-replacement fertility levels. Currently, a temporary acceleration of population ageing is seen in many countries due to the ageing of the large generations born in the mid-twentieth century [1]. Moreover, population ageing has become a global phenomenon and the proportion of older adults in many low- and middle-income countries is increasing at an unprecedented speed [2,3,4,5].

The rising burden of non-communicable diseases induced by population ageing has rightfully been given a lot of attention [6,7,8]. However, morbidity and mortality due to infectious diseases, respiratory infections in particular, remain substantial in the elderly population [9]. The progressive deterioration of immune functions with age (immunosenescene) increases older adults’ susceptibility to infection and their risk of a severe outcome in case of disease [10]. The COVID-19 pandemic, for example, has had a disproportionate impact on the older adult population and on those living in long-term care facilities (LTCFs) in particular [11,12,13,14,15]. Several aspects of LTCFs (e.g. communal meals, group activities, staff rotation) make them an optimal environment for rapid spread of many infectious diseases [16, 17]. Additionally, many LTCF residents have underlying chronic illnesses, which, in addition to their old age, may increase the severity of an infection [18, 19]. Nevertheless, LTCF residents only make up a minority of the older adult population in most high-income countries. The majority of old people typically live alone or with a partner. Moreover, social contact surveys from several European countries have shown that people aged 65 and older have the lowest mean number of contacts [20], and thus fewer interactions that potentially could lead to disease transmission. Consequently, the incidence of infections transmitted via close contact may be relatively low in the oldest age groups, yet the disease burden is typically substantial [21,22,23,24,25].

This implies that high-income countries with ageing populations may face a decreasing overall incidence of an infectious disease (e.g. influenza), but it could coincide with an increasing burden. However, the future burden of infectious diseases in older adults may, among other things, be influenced by the future health and living arrangements at old age. It remains unclear whether the increases in life expectancy are accompanied by a proportionate increase in healthy life expectancy [26,27,28,29]. Health at old age and living arrangements are naturally connected, with relevance for infections transmitted via close contact. The proportion of elderly people living with a partner is expected to increase due to improved longevity, particularly of males [30]. Nevertheless, the proportion living in LTCFs is also likely to increase as the proportion of the oldest people (i.e. 85+) increases [31, 32].

Several studies have investigated the impact of population ageing on the spread and burden of different infectious diseases, including measles, influenza, pneumonia and herpes zoster (e.g. [33,34,35,36,37,38,39,40,41]). Nevertheless, only few studies consider a household-structured population and to our knowledge none of them incorporate LTCFs. We aim to improve the understanding of how changing age and household structures affect the future transmission dynamics and mortality burden of respiratory infections in an ageing population, and explicitly explore the role of living arrangements in the older adult population. Specifically, we consider the Belgian population, which, like most other high-income countries, has a relatively old age structure and is still ageing. We use a demographic microsimulation, which is based on longitudinal microdata drawn from Belgian census and population registers [42]. The microsimulation includes dynamic demographic processes for fertility, mortality, migration and household transitions, making it possible to model the Belgian population over time with evolving age and household structures. In addition to private households, collective households (e.g. LTCFs) are represented in the microsimulation. Due to the uncertainty surrounding the future health and living arrangements of older adults, we consider three demographic scenarios with respect to the proportion of LTCF residents in the population. We refer to the scenarios as low, medium and high to describe the proportion of older adults living in LTCFs relatively to the other scenarios.

We subsequently combine the demographic microsimulation with a disease transmission model representing the spread of SARS-CoV-2 and a novel influenza A virus. The model is a two-level mixing model, which distinguishes between exposure to infection in the household and exposure in the community at large [42]. Additionally, the model implements contact networks within households which are based on empirical data [43]. We simulate outbreaks of SARS-CoV-2 and influenza in a fully susceptible population in 2020, 2030, 2040 and 2050, which allows sufficient time for demographic change to emerge.

We first illustrate how the age and household structures are altered in an ageing population. Secondly, we explore how the changing population structures affect the spread of the two respiratory infections (i.e. incidence) and the burden of mortality in the form of disease-related deaths and quality-adjusted life-years (QALYs) lost. In health economics, QALY expectations (gains or losses) represent a commonly used summary measure of longevity adjusted for the combined impact of death and morbidity [44]. Finally, we investigate to what extent our findings at the individual and population level are affected by changes in the living arrangements in the older adult population.

Methods

We model the host population at the individual level using a demographic microsimulation for Belgium, which is combined with a disease transmission model to simulate the spread of an infection. Each individual is represented by a set of attributes, including age, sex, household membership and disease state. In each time step (i.e. day), the individuals’ attributes may change due to demographic events and events resulting from interactions between individuals (e.g. birth, leaving parental household, union formation, death, social contact and disease transmission). The population is thus evolving over time and demographic changes and disease outbreaks emerging at the population level can be tied to individual events and interactions between individuals.

Demographic microsimulation

We simulate the Belgian population using the microsimulation presented in [42]. The initial population is made up by a household-based sample from the Belgian census in 2011 corresponding to about 10% of the population. For each individual, we have information on their date of birth, sex, ID of parents, birth trajectory (parity and date of most recent birth if applicable), household ID and household position (e.g. in union, child, single parent). Individuals can thus be linked to each other through household membership and kinship. The population evolves over time as individuals can enter and leave the population as a result of births, deaths and migration. Moreover, individuals can move between or create new households, for example as a part of union formation or dissolution. Finally, all individuals are ageing over time and the population is updated accordingly.

The probability of a demographic event taking place varies by individual characteristics, including age, sex and household position, and changes over time except for the household transition rates. We assume that the mortality, fertility and migration levels in the microsimulation are similar to the observed and projected rates by the Belgian Statistical Office (Statbel) and the Belgian Federal Planning Bureau (FPB). This implies below-replacement fertility (a total fertility rate below 2.1 [45]) and continuous improvements in longevity, especially for males [46, 47] (see Figs. S1 and S2 in Additional file 1). Consequently, the population will continue ageing, with implications for the household structures. Fertility trajectory and/or household position are included as covariates in the sub-models for fertility and mortality, as they have been shown to affect the probability of having a(nother) child and dying, respectively [48, 49]

We consider three demographic scenarios pertaining to the household structures in the older adult population (i.e. people aged 75 and older). The large majority of LTCF residents live in a single-person household prior to moving to the LTCF, thus we created three scenarios by varying the probability of leaving a single-person household for people aged 75 and older. The cut-off is made at the age of 75 years since only a small proportion of the population reside in LTCFs at younger ages (see Fig. S3 in Additional file 1). We refer to the scenarios as low, medium and high, as an indication of the proportion of the older adults living in LTCFs. The demographic data, model and source code are described in detail in [42] and section 1 in Additional file 1.

Disease transmission model

In addition to the demographic attributes, all individuals are assigned a disease state. Disease outbreaks take place in the simulated population in 2020, 2030, 2040 and 2050 as ten randomly chosen individuals become infected, in an otherwise fully susceptible population, on January 1st of each respective year. The disease states are thus reset to susceptible and immunity obtained in a prior outbreak is disregarded as a new outbreak begins. The outbreaks are ten years apart to give sufficient time for demographic changes to emerge. We use an SEIR-like (Susceptible-Exposed-Infectious-Recovered) model to describe the spread of respiratory diseases transmitted via close-contact interactions with the examples of COVID-19 and influenza. The probability of becoming infected, and thus moving from the susceptible to exposed state, is calculated using a two-level mixing model, where an individual can become infected as a result of disease transmission within the household or in the general population [50].

Within- and between-household interactions

We use the same techniques as described in [42] to model social interactions, which serve as a proxy for an at-risk event at which infection can be transmitted. Contacts between non-household members in the general population are estimated using social contact data collected in a survey in Belgium in 2010-2011 [20] and made available as a contact matrix through the SOCRATES data tool [51] (see Fig. S6 in Additional file 1). Contacts between household members were excluded, as these are captured by the household level of the model, but contacts taking place in the household with non-household members were included. Additionally, supplementary professional contacts (SPC) were excluded. SPC is a category for individuals with more than 20 professional contacts per day (e.g. bus drivers). These are likely to be less important than other types of contacts when it comes to the transmission of close-contact infectious diseases [52].

For each household, we construct a contact network to model interactions among household members. Contacts are determined to take place using an exponential-family random graph model developed by Krivitsky et al. [43], which was fitted to data from the social contact survey mentioned above [20] and a household contact survey [53], both conducted in Belgium in 2010-2011. The household contact network is, amongst other things, conditional on the type of household and the age-sex composition. In each time step (i.e. day), we apply the fitted model from Krivitsky et al. [43] to generate a contact network for each household in the simulated population. The household contact networks may thus change every day. The mean network density (i.e. the number of links in a household relative to the number of possible links [54]) by household size and type are shown in Fig. S7 in Additional file 1.

Influenza

We formulate an SEIR model to describe the spread of a novel influenza virus such as the influenza A (H1N1)pdm09 virus that emerged in 2009. When acquiring the infection, the individual is not infectious at first (i.e. exposed or latent period), but becomes infectious as the latent period ends and eventually recovers as the infectious period comes to an end. Disease-related mortality is not considered explicitly in the model, but estimated after the simulation. Each susceptible individual i acquires the infection at time t with the probability:

$$\begin{aligned} p_i(t) = 1-\prod _{\begin{array}{c} j\ne i\\ j\in h_i \end{array}} \left( 1-\beta _ha_{ij}(t)I_j(t)\right) \cdot \prod _{j\notin h_i}\left( 1-\beta _pc_{ij}(t)I_j(t)\right) , \end{aligned}$$
(1)

where \(h_i\) denotes the household of individual i and the parameters \(\beta _h\) and \(\beta _p\) represent the probability of disease transmission given contact between a susceptible and infectious individual within the household and in the general population, respectively. We select transmission parameters, \(\beta _h\) and \(\beta _p\), that result in a group-to-group reproduction number (\(R_*\) [50]) of about 1.5, which resembles the basic reproduction number estimated for influenza A(H1N1)pdm09 [55,56,57]. This is further described in section 6 and 7 in Additional file 1. \(I_j(t)\) takes the value one if individual j is infectious at time t and is otherwise zero. The contact network in household \(h_i\) is represented by an adjacency matrix A and the element \(a_{ij}(t)\) equals one if household members i and j come into contact with each other at time t and is otherwise zero. A new adjacency matrix is generated in each time step.

The social contact matrix from Fig. S6 in Additional file 1 contains the mean number of contacts per day in the general population between each age group, \(m_{ij}\), and the probability that individual i and j come into contact with each other at time t given the age groups to which they belong, \(c_{ij}(t)\), is calculated as follows:

$$\begin{aligned} c_{ij}(t)=\dfrac{m_{ij}}{N_j(t)}, \end{aligned}$$
(2)

The element \(m_{ij}\) is divided by \(N_j(t)\), the size of the age group of j at time t, to keep the age-specific contacts constant over time. This implies that we assume disease transmission in the general population to be frequency-dependent, meaning that the number of effective contacts made by each person remains unchanged as the population grows. In each time step, the probability of infection is computed for all susceptible individuals in the population and their disease state is updated accordingly.

The latent period is drawn from a uniform distribution with 1 day as minimum and 5 days as maximum. We assume that the infectious period follows a gamma distribution with a mean of 3.8 days and standard deviation of 2 days [58,59,60]. For each newly infected individual, a value is drawn from the distribution and rounded to the nearest integer. An infected individual recovers and obtains immunity when the infectious period has passed.

COVID-19

In order to model the spread of SARS-CoV-2, we use a model similar to [61], which involves an extension of the SEIR model. Infectious individuals are initially pre-symptomatic and some develop symptoms while others remain asymptomatic (see Fig. 1).

Fig. 1
figure 1

Disease transmission process for COVID-19. Symp.: Symptomatic

Each susceptible individual i acquires infection at time t with probability:

$$\begin{aligned} p_i(t) = 1&- \prod _{\begin{array}{c} j\ne i\\ j\in h_i \end{array}} \left( 1-\beta _{h,a}a_{ij}(t)I_{j,a}(t)s_i\right) \cdot \prod _{\begin{array}{c} j\ne i\\ j\in h_i \end{array}} \left( 1-\beta _{h,s}a_{ij}(t)I_{j,s}(t)s_i\right) \nonumber \\&\quad \cdot \prod _{j\notin h_i}\left( 1-\beta _{p,a}c_{ij}(t)I_{j,a}(t)s_i\right) \cdot \prod _{j\notin h_i}\left( 1-\beta _{p,s}c_{ij}(t)I_{j,s}(t)s_i\right) . \end{aligned}$$
(3)

The same notation is used as for the influenza model, but the subscripts indicate whether the infectious individual is symptomatic (s) or asymptomatic (a). Infected individuals without symptoms are assumed to be half as infectious compared to those with symptoms, however, we acknowledge that this parameter is associated with uncertainty [62, 63]. We select transmission parameters, \(\beta _h\) and \(\beta _p\), that result in a group-to-group reproduction number of about 3, to reflect the estimated basic reproduction number in Belgium prior to lockdown [61, 64, 65]. This is further described in section 6 and 7 in Additional file 1.

\(I_{j,a}(t)\) (\(I_{j,s}(t)\)) takes the value one if individual j is infectious and asymptomatic (symptomatic) at time t and is otherwise zero. The parameter \(s_i\) represents age-specific susceptibility and is 0.5 if individual i is younger than 18 years of age and is otherwise one, as we assume that children and teenagers are half as susceptible as adults [66]. The incubation period contains a latent period and a pre-symptomatic period. In the latent period, the individual is infected but not yet infectious, whereas the individual is infectious in the pre-symptomatic period, but shows no symptoms (yet). The incubation period is based on findings from [62, 67] and is assumed to follow a log-normal distribution with mean and standard deviation on the log scale of 1.43 and 0.66, respectively (see Fig. S10 in Additional file 1). The incubation period spans over at least two days since we assume that infectiousness starts one day prior to symptom onset at the latest and one day after infection at the earliest.

Based on infectiousness profiles from [67], a discrete distribution for the pre-symptomatic infectious period was estimated in [61] (see Fig. S11 in Additional file 1). For each newly infected individual, we draw from the distributions for the incubation period and the pre-symptomatic period. The length of the latent period for a given individual is obtained by subtracting the sampled value for the pre-symptomatic period from that of the incubation period (after rounding to a discrete number of days).

The distribution of the infectious period (including pre-symptomatic period) is assumed to follow a normal distribution with a mean of six days and a standard deviation of one (see Fig. S12 in Additional file 1). For each infected individual, the length of the infectious period is drawn from the distribution and the pre-symptomatic period is subtracted in order to obtain the remaining days of infectiousness. It is determined whether the individual shows symptoms during this period according to age-specific probabilities estimated in [61] (see Fig. S13 in Additional file 1). The probability of being symptomatic is based on the age-specific relative susceptibility to symptomatic infection reported in [68] assuming 50% of the overall cases in the population to be symptomatic. An infected individual recovers and obtains immunity when the infectious period has passed. We run 50 simulations using the COVID-19 and influenza models, respectively, but limit our analysis to those simulations where an outbreak takes place (i.e. total attack rate of at least 0.5%).

Disease-related mortality

We estimate influenza-related deaths by applying the infection fatality rates (IFRs) for the influenza A(H1N1)pdm09 pandemic estimated by Riley et al. [69] based on a serological survey of a cohort of households in Hong Kong (see Fig. S14 in Additional file 1). The rates are by age group, but no estimates are available for children younger than three years. Consequently, we apply the IFR of the age group 3-19 to all ages younger than 19, although this is likely to underestimate the fatalities in the youngest children. For COVID-19, we use IFRs estimated by Molenberghs et al. [15] for Belgium in the period March 8th to May 9th 2020. The IFRs are broken down by age and household type (see Fig. S15 in Additional file 1). The considered household types are LTCFs and non-LTCFs. For ages younger than 60 years, there is no distinction between the household types, likely due to the small number of LTCF residents of that age. LTCF residents are not directly identifiable in the demographic microsimulation. Therefore, we use the household position collective as a proxy. This household position covers residents in different types of institutions, including prisons and LTCFs, but we expect the large majority of older adults with that household position to actually be living in LTCFs.

Quality-adjusted life years

To provide an estimate of the potential years of life lost due to premature death and the health-related quality of those years of life lost, we estimate the QALY losses attributable to COVID-19 and influenza fatalities using the method presented by Briggs et al. [70]. Pre-existing comorbidities are associated with an increased risk of a fatal outcome upon infection with SARS-CoV-2 or influenza [71,72,73], which is taken into account when estimating the QALY losses (see further details in section 10 in Additional file 1). However, we do not consider QALY losses from morbidity due to non-fatal infections.

Results

Population ageing

The population is ageing during the whole simulation period. Between 2020 and 2030, it is primarily due to an increasing proportion aged 65-79 years, while the age group 80 years and older increases fastest in the remaining decades (see Fig. 2 left panel). This reflects the ageing of the large generations born in the mid-twentieth century. Population ageing induces changes in the household size distribution (see Fig. 2 right panel). The elderly population primarily lives in small households (size 1-2) or very large households in the form of LTCFs (see Fig. S3 in Additional file 1). Consequently, an increasing proportion of the population lives in households of these sizes (1, 2 and 8+) as the population is ageing. Additionally, households of nuclear families are decreasing in size due to low fertility and an increase in single-parent families. It should be noted that the group size 8+ primarily is made up by LTCFs, which tend to have 25-100 residents in the simulated population.

Fig. 2
figure 2

Age and household-size distribution by simulation year and scenario (medium: bar, low: square, high: circle)

The differences in the demographic scenarios only slightly affect the age distribution. The proportion aged 80 years and older is marginally larger in the scenario low (square) than in medium (bar) and high (dot), because of the smaller proportion of LTCF residents, which have a higher all-cause mortality (for further information on all-cause mortality in the microsimulation see section 1 in Additional file 1). The demographic scenarios have a more profound impact on the household size distribution. The proportion in household size 1 and 8+ in scenario low (square) and high (dot) gradually diverge from the medium scenario (bar), but in opposite directions. Consequently, the proportion living in LTCFs (i.e. size 8+) relative to the proportion living alone is highest in the scenario high and lowest in scenario low, while the medium scenario is in between. The other household sizes are more or less unaffected. Household size distributions by age groups, scenario and simulation year can be seen in Figs. S4 and S5 in Additional file 1.

Transmission dynamics

As expected, the proportion of the population that becomes infected during an outbreak (attack rate) in the COVID-19 model is substantially larger than for influenza (see Fig. S16 in Additional file 1), due to the differences in the transmission parameters. The attack rate is decreasing over time in both models, but after 2040, a slight increase is seen for influenza (see Fig. S17 in Additional file 1). Older adults, which are increasingly replacing the younger population, have relatively fewer contacts on average since the majority live in small households (see Fig. S3 in Additional file 1) and have fewer contacts in the general population (see Fig. S6 in Additional file 1). Consequently, the older adult population has a lower risk of acquiring and transmitting an infection than younger age groups.

The age-specific attack rates in the COVID-19 and influenza models naturally differ in magnitude, but other patterns are also seen (see Fig. 3, note different scales on y-axes). For COVID-19 (Fig. 3, upper panel), the attack rate is largest in the adult population, which reflects the lower susceptibility of children and the increasing probability of being symptomatic and thereby more contagious with age. Meanwhile, influenza (Fig. 3, lower panel) is more prevalent in children and adolescents compared to adults, which is resulting from the age-specific differences in contact patterns within and outside the household. This indirectly affects the parental generation (i.e. ages 30-49), which has the highest incidence in the adult population. In both models, the attack rate in the elderly population is shaped by the proportion of the age groups living in LTCFs, as the risk of infection increases with household size (see Fig. S19 in Additional file 1).

Fig. 3
figure 3

Mean age-specific attack rates by simulation year, model and demographic scenario. Note the different scales on y-axes

These age patterns in the transmission processes imply that the impact of population ageing on the spread of COVID-19 and influenza differ. Since children and adolescents are the main drivers in influenza transmission, the attack rate declines substantially as the nuclear families decrease in size (i.e. low fertility and increase in single-parent families) and are increasingly being replaced by elderly people with a relatively low risk of infection (see Fig. S17 in Additional file 1). Meanwhile, the decrease in the attack rate of COVID-19 is less pronounced, and barely observed for the 20- to 79-year-olds (see Fig. S18 in Additional file 1). The risk of community transmission in the young and middle-aged adult population remains substantial (i.e. at work-places) due to the increased probability of being symptomatic and the assumption of frequency-dependent transmission. Moreover, old people (i.e. 70+) account for a larger share of infections with COVID-19 than with influenza, thus the decrease in the overall attack rate of COVID-19 induced by population ageing is less pronounced.

Since the population is ageing, the age composition of the infected people in the population is also shifting, but not necessarily to the same degree. In Fig. 4, we compare the relative change in the age distribution (black bars) to the relative change in the age distribution of infected people (blue bars), both as a proportion of the total population size in simulation year 2030, 2040 and 2050 and using the corresponding values for 2020 as the reference. Infected people younger than 65 years of age make up a decreasing proportion of the population, while the proportion of infected people aged 65 and older is increasing, as to be expected considering the changes in the age distribution. The proportion of infected children and adolescents (i.e. younger than 18 years) in the population is decreasing more than the overall proportion of the age group across all demographic scenarios and models. This results from the decreasing household size of nuclear families (see Fig. S4 in Additional file 1), which is associated with a lower risk of infection for children and their parents as described earlier. Nevertheless, in the COVID-19 model, young and middle-aged adults experience a more or less equal relative change in the proportions since community transmission is more pronounced. This is also the case for age group 50-64 in the influenza model, but due to an increasing mean household size as the share living together with their adult children is increasing. The growth in the proportion of infected 65 to 79-year-olds in the population is slower than the overall growth in the age group, as the share living in single-person households is increasing, especially for people in their seventies.

Fig. 4
figure 4

Mean relative change in size of age group (black bars) and number of infected people in age group (blue bars) as proportion of total population compared to 2020. Demographic scenarios by row and models by column

The relationship between the growth in the proportion of infected people aged 80 and older in the population and the general growth in the age group vary by demographic scenario. In the medium scenario, the growth rates are very similar, meaning that the age group is barely benefitting from the lower transmission in the young population. First of all, older adults have few contacts with children and adolescents. Second of all, the share of the age group 80+ living with a partner instead of alone is increasing. Finally, the age group is increasingly made up by people aged 90 and older, which have a higher attack rate.

In the scenario with a relatively low and decreasing share of the population living in LTCFs (first row in Fig. 4), the proportion of infected people aged 80 years and older in the population is growing at a slower rate than the age group overall, while this relationship is reversed in the scenario with a high and slightly increasing share living in LTCFs (third row in Fig. 4). The differences between the scenarios low and high for age group 80+ are generally larger in the influenza model than in the COVID-19 model. The risk of infection for an elderly person living in a small household compared to someone living in an LTCF differs substantially more in the influenza model than in the COVID-19 model, thus the response to the scenarios is more pronounced in the first case (see Fig. S20 in Additional file 1). This is again related to the age-specific susceptibility and infectiousness in the COVID-19 model.

Burden of disease-related mortality

Although the overall attack rate is decreasing over time, the number of deaths per 1,000 people in the population is increasing, due to the shift in the age distribution of the infected population (see Fig. S21 in Additional file 1). Since the applied fatality rates are associated with substantial uncertainty, we limit the analysis of disease-related deaths to a comparison across time, age and demographic scenarios. Deaths attributable to COVID-19 are highly concentrated in the older adult population (see Fig. 5, upper panel). Influenza-related deaths are also more pronounced in the older adult population, however, differences within the older age groups only reflect differential attack rates since the same IFR is applied to everyone aged 60 and older. The differences in fatalities between the demographic scenarios are induced by the aforementioned relationship between the proportion of infected older adults and the proportion of those living in LTCFs. Moreover, the applied IFRs for COVID-19 from [15] are broken down by household type (i.e. LTCF vs. non-LTCF), hence the number of COVID-19 deaths in our simulation is more sensitive to changes in the population living in LTCFs.

Fig. 5
figure 5

Mean age-specific disease-related death rate by year, model and demographic scenario. Note the different scales on y-axes

Clearly, the average number and quality of years of life lost due to a premature death decrease with age. The middle-aged adults thus account for a larger share of the total QALY losses than of the fatalities (Fig. 6, row one and three, note different Y-axis scales). However, the largest QALY losses in absolute values are seen in the 60-79 year olds for both COVID-19 and influenza. When taking the age distribution into account, the QALY losses become more pronounced in the oldest age groups (see Fig. 6, row two and four). In both models, the total QALY losses are increasing over time and at a rate slightly higher than that of the increase in deaths (see Fig. S21 in Additional file 1). Moreover, the age-specific QALY losses per 1,000 people are increasing in several age groups despite a stable or even decreasing disease-related death rate (see Fig. 6), because life expectancy is increasing. In 2020, for example, the average life expectancy of a 75 year old is about 12 years, while it is expected to increase to 15 years by 2050 (see Fig. S22 in Additional file 1). However, the COVID-19 related QALY losses per 1,000 people in age group 90+ is decreasing between 2030 and 2050 for the demographic scenarios with a low or medium proportion of older adults living in LTCFs. The increasing life expectancy in this age group cannot compensate for the decrease in deaths associated with the changing living arrangements.

Fig. 6
figure 6

Mean age-specific QALY losses in total and per 1,000 people by year and demographic scenario

Discussion

Increasing life expectancy and persistently low fertility levels have led to old population age structures in most high-income countries, and population ageing is ongoing as the large generations born in the mid-twentieth century move into the older age categories [1]. Population ageing has potential implications for the burden of infectious diseases as the morbidity and mortality of many infections are concentrated in the older adult population [9, 10], as seen in the COVID-19 pandemic. The demographic microsimulation and two-level mixing model applied in our study allow to investigate the potential impact of population ageing on the transmission dynamics and burden of COVID-19 and influenza, while explicitly considering changes in the household structures, particularly among the older adults. Our focus on the future living arrangements in the older adult population is motivated by the disproportionate burden of the COVID-19 pandemic among LTCF residents [11, 12, 14, 15].

Our results suggest that population ageing on the one hand is associated with smaller total attack rates in COVID-19 and influenza epidemics, but on the other hand is causing a substantially larger disease burden of mortality, even if the proportion of older adults living in LTCFs were to decrease. Moreover, we find that not only the shift in the age distribution, but also the induced changes in the household structures are important to consider when assessing the potential impact of population ageing on the transmission and burden of respiratory infections.

Respiratory infections are predominantly caught by close contact with an infectious individual and transmission often takes place between household members [74, 75]. Since older adults in Belgium have few contacts and the majority live alone or with their partner, the number of occasions where they could acquire a respiratory disease is relatively low. A decrease in the overall attack rate of COVID-19 and influenza is thus a logical consequence of population ageing. This relationship, however, is modified by the age pattern in the attack rates, which in turn is influenced by the susceptibility to and infectiousness upon infection as well as contact patterns.

In our simulation, COVID-19 attack rates were highest in the young and middle-aged adult population, while influenza incidence was highest in children and adolescents, which is in line with serological studies [76, 77]. Moreover, older adults made up a larger share of the infected population in the COVID-19 model than in the influenza model. Consequently, the increasing proportion of older people in the population led to a greater relative decline in the overall number of influenza infections, which was amplified by the decreasing size of nuclear families, as they play an important role in influenza transmission. The changing composition of nuclear families resulted from a decreasing fertility rate prior to 2020, which recovered slowly, but not fully, in the remaining simulation period, similar to observed and projected rates by Statbel and FPB [47]. Additionally, single-parent families became more prevalent. As a result of this, the average influenza incidence in children and the parental generation declined. This was less pronounced in the COVID-19 model, where the attack rate in the young and middle-aged adults were more or less unchanged due to substantial community transmission (i.e. at work-places).

Since older adults have the lowest number of community contacts [78], their risk of infection is highly dependent on their living arrangements. Older people in Belgium tend to either live in very small households (alone or with a partner) or in very large LTCFs. Several typical aspects of LTCFs, such as the size, shared meals, group activities, staff rotation, visitors, makes it easy for an infection to enter and spread rapidly [16, 17]. The variability in older adults’ risks of infection is thus considerably larger than in any other age group. This implies that the future incidence in the older adult population is closely connected to changes in their household structures.

In the microsimulation, single-person households (e.g. a widow) in the age group 80+ are increasingly being replaced by two-person households (e.g. a couple), as the sex differential in mortality diminishes due to larger improvements in the life expectancy of males than in that of females. On the one hand, living with a partner instead of living alone increases the risk of infection as household transmission becomes a possibility. On the other hand, the probability of moving to a LTCF, which is associated with a substantially higher risk of infection, is markedly lower for elderly people living with a partner than for those living alone. However, the future mortality, health and living arrangements in the older adult population are associated with a large degree of uncertainty [26,27,28,29,30, 79]. Therefore, we presented three demographic scenarios pertaining to the proportion of older adults living in LTCFs relative to the proportion living alone.

The attack rates in the old age groups follow the proportion living in LTCFs and therefore differ substantially between the demographic scenarios. However, the sensitivity of the attack rates to household structures among older adults was larger for influenza than for COVID-19. This is again related to the different age patterns in disease transmission. The risk of acquiring COVID-19 remains relatively high for older non-LTCF residents because their susceptibility is high and the few contacts they do have will typically be with other old people, which are most likely to be symptomatic in case of infection and thereby more contagious. The influenza attack rate in older non-LTCF residents is markedly lower than other population groups, as children and adolescents are the main drivers of the spread and rarely live together with old people and generally have few contacts with them. Meanwhile, the attack rate for LTCF residents of COVID-19 as well as influenza are the highest in the population. Thus, the larger differential in the influenza attack rates between LTCF and non-LTCF residents imply that the overall attack rate of the older adults responds stronger, in relative terms, to changes in the living arrangements.

Although population ageing is associated with a decreasing proportion of infected people in the total population, disease-related deaths and QALY losses are increasing substantially. The lost QALYs increase faster than the deaths because a projected increase in life expectancy is accounted for in the QALY estimations. The speed at which the burden increases is influenced by the living arrangements among older adults, which can be considered a proxy for the health at old age. However, even in a scenario with a diminishing proportion of LTCF residents, the burden of disease-related mortality increases considerably in the whole simulation period.

We emphasise that our study is an investigation of the effects of population ageing on transmission dynamics and burden of disease-related mortality, and the results should not be interpreted as predictions. Moreover, our findings should be seen in the light of several limitations. First, we restricted our study to emerging infectious diseases by assuming that the initial population is fully susceptible and we did not consider behavioural changes (e.g. changing contact patterns) during the outbreak, which would reduce the size of the simulated outbreaks. Additionally, age patterns of prior immunity or mitigation strategies in certain population groups (e.g. LTCFs, schools) may shift the age distribution of the infected population and thereby modify the impact of population ageing. For example, some degree of pre-existing immunity to influenza A (H1N1)pdm09 was found in older adults, which may have resulted from exposure to H1N1 viruses earlier in life [76]. Nevertheless, we disregard these elements in order to obtain a clear understanding of the effects of population ageing alone.

Second, we do not distinguish between locations at which social contacts take place outside the households (i.e. schools, workplaces) and the patterns of social contacts in the general population are assumed ot remain constant over time, since little is known about how contact patterns are affected by changing population structures. Nevertheless, the household contact patterns change along with the household composition as we generate new household networks in each time-step (i.e. day). The extrapolation of household contact networks for private households to LTCFs may be questionable due to the different structures, compositions and relations within the households. However, the large outbreaks among LTCF residents in our simulation reflect estimations of COVID-19 cases and the spread in LTCFs in Belgium prior to the implementation of mitigation measures [15, 80].

Third, the model for influenza was less detailed than that of COVID-19 due to differences in the availability of detailed epidemiological and clinical data, such as age-specific susceptibility and probability of developing symptoms.

Finally, our estimates of disease burden are based on adjusting the QALYs lost due to deaths attributable to COVID-19 and influenza, but do not include QALY losses from morbidity due to non-fatal COVID-19 or influenza. Furthermore, our QALY estimates are associated with a considerable degree of uncertainty pertaining to the applied IFRs and the parameter settings in the QALY estimations. Moreover, we applied constant IFRs and parameters in the QALY estimations. The alternative parameter settings suggested in Briggs et al. [70] for the estimation of QALYs did not change the relationships we obtained. Nevertheless, the age-specific morbidity and mortality associated with respiratory diseases may change over time because of medical innovations and/or improved health at old age. Developments in healthy life expectancy, however, remain unclear [26,27,28,29]. We partially addressed this uncertainty with the demographic scenarios in our analysis.

Conclusions

Population ageing is associated with smaller outbreaks of emerging respiratory infections such as SARS-CoV-2 and novel influenza A virus. Nevertheless, the burden of mortality increases substantially, even if the population living in LTCFs, which typically face a high risk of infection as well as a fatal outcome, were to decrease. The variability in older adults’ risks of infection is considerably larger than in any other age group, which is related to their living arrangements. Not only the shift in the age distribution, but also the induced changes in the household structures are important to consider when assessing the potential impact of population ageing on the transmission and burden of emerging respiratory infections. Age patterns in epidemiological parameters may exacerbate or alleviate these relationships.

Availability of data and materials

The input data of this study are available from Statics Belgium but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. A detailed description of the data and source code are available from the GitHub repository: https://github.com/signemoegelmose/demographic_microsimulation_EXTERNAL.

Code availability

The source code is available from the GitHub repository: https://github.com/signemoegelmose/demographic_microsimulation_EXTERNAL.

References

  1. Lanzieri G. The greying of the baby boomers. A century-long view of ageing in European populations. Technical report. 2011.

  2. Gavazzi G, Herrmann F, Krause KH. Aging and infectious diseases in the developing world. Clin Infect Dis. 2004;39(1):83–91. https://doi.org/10.1086/421559.

    Article  PubMed  Google Scholar 

  3. Preston SH, Stokes A. Sources of Population Aging in More and Less Developed Countries. Popul Dev Rev. 2012;38(2):221–36. https://doi.org/10.1111/j.1728-4457.2012.00490.x.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Shetty P. Grey matter: Ageing in developing countries. Lancet. 2012;379(9823):1285–7. https://doi.org/10.1016/S0140-6736(12)60541-8.

    Article  PubMed  Google Scholar 

  5. United Nations Department of Economic and Social Affairs. World Population Ageing 2019. Technical report, Department of Economic and Social Affairs, Population Division. 2019.

  6. Chaker L, Falla A, van der Lee SJ, Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on macro-economic productivity: a systematic review. Eur J Epidemiol. 2015;30(5):357–95. https://doi.org/10.1007/s10654-015-0026-5.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kämpfen F, Wijemunige N, Evangelista B. Aging, non-communicable diseases, and old-age disability in low- and middle-income countries: a challenge for global health. Int J Pub Health. 2018;63(9):1011–2. https://doi.org/10.1007/s00038-018-1137-z.

    Article  Google Scholar 

  8. Xi JY, Lin X, Hao YT. Measurement and projection of the burden of disease attributable to population aging in 188 countries, 1990-2050: A population-based study. J Global Health. 2022;12. https://doi.org/10.7189/jogh.12.04093.

  9. Kassebaum NJ. Global, regional, and national burden of diseases and injuries for adults 70 years and older: Systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022;376. https://doi.org/10.1136/bmj-2021-068208.

  10. Haynes L. Aging of the Immune System: Research Challenges to Enhance the Health Span of Older Adults. Front Aging. 2020;1(October):1–4. https://doi.org/10.3389/fragi.2020.602108.

    Article  Google Scholar 

  11. Cronin CJ, Evans WN. Nursing home quality, COVID-19 deaths, and excess mortality. J Health Econ. 2022;82;102592.

  12. Fisman DN, Bogoch I, Lapointe-Shaw L, McCready J, Tuite AR. Risk Factors Associated with Mortality among Residents with Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada. JAMA Netw Open. 2020;3(7):1–7. https://doi.org/10.1001/jamanetworkopen.2020.15957.

    Article  Google Scholar 

  13. Henry NJ, Elagali A, Nguyen M, Chipeta MG, Moore CE. Variation in excess all-cause mortality by age, sex, and province during the first wave of the COVID-19 pandemic in Italy. Sci Rep. 2022;12(1):1–12. https://doi.org/10.1038/s41598-022-04993-7.

    Article  CAS  Google Scholar 

  14. Modig K, Lambe M, Ahlbom A, Ebeling M. Excess mortality for men and women above age 70 according to level of care during the first wave of COVID-19 pandemic in Sweden: A population-based study. Lancet Reg Health Europe. 2021;4:100072. https://doi.org/10.1016/j.lanepe.2021.100072.

    Article  CAS  PubMed  Google Scholar 

  15. Molenberghs G, Faes C, Verbeeck J, Deboosere P, Abrams S, Willem L, et al. COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020. Eurosurveillance. 2022;27(7):1–10. https://doi.org/10.2807/1560-7917.ES.2022.27.7.2002060.

    Article  Google Scholar 

  16. Gardner W, States D, Bagley N. The Coronavirus and the Risks to the Elderly in Long-Term Care. J Aging Soc Policy. 2020;32(4–5):310–5. https://doi.org/10.1080/08959420.2020.1750543.

    Article  PubMed  Google Scholar 

  17. Strausbaugh LJ, Sukumar SR, Joseph CL. Infectious disease outbreaks in nursing homes: An unappreciated hazard for frail elderly persons. Clin Infect Dis. 2003;36(7):870–6. https://doi.org/10.1086/368197.

    Article  PubMed  Google Scholar 

  18. Garibaldi RA. Residential care and the elderly: the burden of infection. J Hosp Infect. 1999;43(Suppl):S9–18. https://doi.org/10.1016/s0195-6701(99)90061-0.

  19. Gaspard P, Mosnier A, Simon L, Ali-Brandmeyer O, Rabaud C, Larocca S, et al. Gastroenteritis and respiratory infection outbreaks in French nursing homes from 2007 to 2018: Morbidity and all-cause lethality according to the individual characteristics of residents. PLoS ONE. 2019;14(9):1–15. https://doi.org/10.1371/journal.pone.0222321.

    Article  CAS  Google Scholar 

  20. Hoang TV, Coletti P, Kifle YW, Kerckhove KV, Vercruysse S, Willem L, et al. Close contact infection dynamics over time: insights from a second large-scale social contact survey in Flanders, Belgium, in 2010–2011. BMC Infect Dis. 2021;21(1):1–15. https://doi.org/10.1186/s12879-021-05949-4.

    Article  Google Scholar 

  21. Bartoszko J, Loeb M. The burden of influenza in older adults: meeting the challenge. Aging Clin Exp Res. 2021;33(3):711–7. https://doi.org/10.1007/s40520-019-01279-3.

    Article  PubMed  Google Scholar 

  22. Glynn JR, Moss PAH. Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children. Sci Data. 2020;7(1):1–13. https://doi.org/10.1038/s41597-020-00668-y.

    Article  CAS  Google Scholar 

  23. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: Systematic review and meta-analysis. BMJ (Online). 2013;347(7923):1–15. https://doi.org/10.1136/bmj.f5061.

    Article  Google Scholar 

  24. Moa AM, Menzies RI, Yin JK, MacIntyre CR. Modelling the influenza disease burden in people aged 50–64 and ≥ 65 years in Australia. Influenza Other Respir Viruses. 2022;16(1):132–41. https://doi.org/10.1111/irv.12902.

  25. Wing K, Grint DJ, Mathur R, Gibbs HP, Hickman G, Nightingale E, et al. Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform. Int J Epidemiol. 2022;51(6). https://doi.org/10.1093/ije/dyad041.

  26. Beltrán-Sánchez H, Soneji S, Crimmins EM. Past, Present, and future of healthy life expectancy. Cold Spring Harb Perspect Med. 2015;5(11):a025957. https://doi.org/10.1101/cshperspect.a025957.

  27. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–208. https://doi.org/10.1016/S0140-6736(09)61460-4.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380(9859):2144–62. https://doi.org/10.1016/S0140-6736(12)61690-0.

    Article  PubMed  Google Scholar 

  29. Vaupel JW, Villavicencio F, Bergeron-Boucher MP. Demographic perspectives on the rise of longevity. Proc Natl Acad Sci USA. 2021;118(9):1–10. https://doi.org/10.1073/pnas.2019536118.

    Article  CAS  Google Scholar 

  30. Keilman N, Christiansen S. Norwegian Elderly Less Likely to Live Alone in the Future. Eur J Popul. 2010;26(1):47–72. https://doi.org/10.1007/s10680-009-9195-9.

    Article  Google Scholar 

  31. Evans CJ, Ho Y, Daveson BA, Hall S, Higginson IJ, Gao W. Place and Cause of Death in Centenarians: A Population-Based Observational Study in England, 2001 to 2010. PLoS Med. 2014;11(6):1–13. https://doi.org/10.1371/journal.pmed.1001653.

    Article  Google Scholar 

  32. Poulain M, Dal L, Herm A. Trends in living arrangements and their impact on the mortality of older adults: Belgium 1991–2012. Demogr Res. 2020;43:401–30. https://doi.org/10.4054/DEMRES.2020.43.15.

    Article  Google Scholar 

  33. Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, et al. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis. 2014;14(1). https://doi.org/10.1186/1471-2334-14-365.

  34. Geard N, Glass K, McCaw JM, McBryde ES, Korb KB, Keeling MJ, et al. The Effects of Demographic Change on Disease Transmission and Vaccine Impact in a Household Structured Population. Epidemics. 2015;13:56–64. https://doi.org/10.1016/j.epidem.2015.08.002.

    Article  PubMed  Google Scholar 

  35. Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, et al. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. BMC Med. 2018;16(3). https://doi.org/10.1186/s12916-017-0983-5.

  36. McDonald SA, van Lier A, Plass D, Kretzschmar ME. The Impact of Demographic Change on the Estimated Future Burden of Infectious Diseases: Examples from Hepatitis B and Seasonal Influenza in the Netherlands. BMC Public Health. 2012;12(1046). https://doi.org/10.1186/1471-2458-12-1046.

  37. Melegaro A, Marziano V, Del Fava E, Poletti P, Tirani M, Rizzo C, et al. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: A modelling and cost-effectiveness study. BMC Med. 2018;16(117). https://doi.org/10.1186/s12916-018-1094-7.

  38. Talbird SE, La EM, Carrico J, Poston S, Poirrier JE, DeMartino JK, et al. Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States. Hum Vaccines Immunotherapeutics. 2020. https://doi.org/10.1080/21645515.2020.1780847.

  39. Williams JR, Manfredi P, Melegaro A. The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: The case of hepatitis B. BMC Med. 2018;16(1):1–13. https://doi.org/10.1186/s12916-018-1100-0.

    Article  Google Scholar 

  40. Williams JR, Manfredi P. Ageing Populations and Childhood infections: The Potential Impact on Epidemic patterns and Morbidity. Int J Epidemiol. 2004;33:566–72. https://doi.org/10.1093/ije/dyh098.

    Article  PubMed  Google Scholar 

  41. Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, et al. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis. 2012;205(10):1589–92. https://doi.org/10.1093/infdis/jis240.

    Article  PubMed  Google Scholar 

  42. Møgelmose S, Vijnck L, Neven F, Neels K, Beutels P, Hens N. Population age and household structures shape transmission dynamics of emerging infectious diseases : a longitudinal microsimulation approach. medRxiv. 2023;2023.06.05. https://doi.org/10.1101/2023.06.05.23290874.

  43. Krivitsky PN, Coletti P, Hens N. A Tale of Two Datasets: Representativeness and Generalisability of Inference for Samples of Networks. arXiv: 2202.03685. 2022.

  44. Gold MR, Stevenson D, Fryback DG. HALYs and QALYs and DALYs, Oh My: Similarities and Differences in Summary Measures of Population Health. Annu Rev Public Health. 2002;23(1):115–34. https://doi.org/10.1146/annurev.publhealth.23.100901.140513.

    Article  PubMed  Google Scholar 

  45. Preston SH, Heuveline P, Guillot M. Demography. Measuring and Modeling Population Processes. Oxford: Blackwell Publishers; 2001.

    Google Scholar 

  46. Federaal Planbureau. Prospectieve sterftequotiënten. Technical Report December 2009.

  47. Vandresse M. Federal Planning Bureau. Modelling fertility for national population projections. The case of Belgium. Technical report, Federal Planning Bureau (Belgium). 2020.

  48. Gadeyne S. The ultimate inequality: socio-economic differences in all-cause and cause-specific mortality in Belgium in the first part of the 1990s. Brussels: NIDI/CBGS Publications; 2006.

    Google Scholar 

  49. Neels K. Reproductive strategies in Belgian fertility, 1960–1990. Brussels: NIDI/CBGS Publications; 2006.

    Google Scholar 

  50. Ball F, Mollison D, Scalia-Tomba G. Epidemics with Two Levels of Mixing. Ann Appl Probab. 1997;7(1):46–89.

    Article  Google Scholar 

  51. Willem L, Van Hoang T, Funk S, Coletti P, Beutels P, Beutels P, et al. SOCRATES: An online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19. BMC Res Notes. 2020;13(1):1–8. https://doi.org/10.1186/s13104-020-05136-9.

    Article  CAS  Google Scholar 

  52. Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, et al. The French connection: The first large population-based contact survey in France relevant for the spread of infectious diseases. PLoS ONE. 2015;10(7):1–22. https://doi.org/10.1371/journal.pone.0133203.

    Article  CAS  Google Scholar 

  53. Goeyvaerts N, Santermans E, Potter G, Torneri A, Van Kerckhove K, Willem L, et al. Household members do not contact each other at random: Implications for infectious disease modelling. Proc R Soc B Biol Sci. 2018;285(1893). https://doi.org/10.1098/rspb.2018.2201.

  54. O’Malley AJ, Marsden PV. The analysis of social networks. Health Serv Outcome Res Methodol. 2008;8(4):222–69. https://doi.org/10.1007/s10742-008-0041-z.

    Article  Google Scholar 

  55. Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: A systematic review of the literature. BMC Infect Dis. 2014;14(1):1–20. https://doi.org/10.1186/1471-2334-14-480.

    Article  Google Scholar 

  56. Cowling BJ, Lau MSY, Ho LM, Chuang SK, Tsang T, Liu SH, et al. The effective reproduction number of pandemic influenza: Prospective estimation. Epidemiology. 2010;21(6):842–6. https://doi.org/10.1097/EDE.0b013e3181f20977.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238–44. https://doi.org/10.1016/S1473-3099(20)30484-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–85. https://doi.org/10.1093/aje/kwm375.

    Article  PubMed  Google Scholar 

  59. Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boëlle PY. A Bayesian MCMC approach to study transmission of influenza: Application to household longitudinal data. Stat Med. 2004;23(22):3469–87. https://doi.org/10.1002/sim.1912.

    Article  CAS  PubMed  Google Scholar 

  60. Glasser J, Taneri D, Feng Z, Chuang JH, Tüll P, Thompson W, et al. Evaluation of targeted influenza vaccination strategies via population modeling. PLoS ONE. 2010;5(9):1–8. https://doi.org/10.1371/journal.pone.0012777.

    Article  CAS  Google Scholar 

  61. Willem L, Abrams S, Libin PJK, Coletti P, Kuylen E, Petrof O, et al. The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19. Nat Commun. 2021;12(1):1–9. https://doi.org/10.1038/s41467-021-21747-7.

    Article  CAS  Google Scholar 

  62. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199–207. https://doi.org/10.1056/nejmoa2001316.

    Article  PubMed  PubMed Central  Google Scholar 

  63. McEvoy D, McAloon C, Collins A, Hunt K, Butler F, Byrne A, et al. Relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review. BMJ Open. 2021;11(5):1–8. https://doi.org/10.1136/bmjopen-2020-042354.

    Article  Google Scholar 

  64. Abrams S, Wambua J, Santermans E, Willem L, Kuylen E, Coletti P, et al. Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories. Epidemics. 2021;35:100449. https://doi.org/10.1016/j.epidem.2021.100449.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Coletti P, Libin P, Petrof O, Willem L, Abrams S, Herzog SA, et al. A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies. BMC Infect Dis. 2021;21(1):1–12. https://doi.org/10.1186/s12879-021-06092-w.

    Article  CAS  Google Scholar 

  66. Franco N, Coletti P, Willem L, Angeli L, Lajot A, Abrams S, et al. Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data. PLoS Comput Biol. 2022;18(3):1–17. https://doi.org/10.1371/journal.pcbi.1009965.

    Article  Google Scholar 

  67. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–5. https://doi.org/10.1038/s41591-020-0869-5.

    Article  CAS  PubMed  Google Scholar 

  68. Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26(4):506–10. https://doi.org/10.1038/s41591-020-0822-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, Wu JT, et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med. 2011;8(6). https://doi.org/10.1371/journal.pmed.1000442.

  70. Briggs AH, Meacock R, Goldstein DA, Kirwin E, Wisløff T. Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19. Health Econ. 2022;30:699–707. https://doi.org/10.1002/hec.4208.

    Article  Google Scholar 

  71. Adab P, Haroon S, O’Hara ME, Jordan RE. Comorbidities and covid-19. BMJ. 2022;19–20. https://doi.org/10.1136/bmj.o1431.

  72. Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021;11:1–23. https://doi.org/10.3389/fphys.2020.571416.

    Article  Google Scholar 

  73. Pérez-Flores E, Izquierdo-Puente JC, Castillo-Pérez JJ, Ramírez-Rosales G, Grijalva-Otero I, López-Macías C, et al. Quantifying the mortality caused by the H1N1 influenza virus during the 2009 pandemic in Mexico. J Infect Dev Countries. 2014;8(6):742–8. https://doi.org/10.3855/jidc.3622.

    Article  Google Scholar 

  74. House T, Keeling MJ. Household Structure and Infectious Disease Transmission. Epidemiol Infect. 2009;137:654–61. https://doi.org/10.1017/S0950268808001416.

    Article  CAS  PubMed  Google Scholar 

  75. Keeling MJ, Rohani P. Modeling Infectious Diseases in Humans and Animals. Princeton: Princeton University Press; 2007. https://doi.org/10.2307/j.ctvcm4gk0.

    Book  Google Scholar 

  76. Reed C, Katz JM, Hancock K, Balish A, Fry AM. Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic. PLoS ONE. 2012;7(10). https://doi.org/10.1371/journal.pone.0048187.

  77. Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396. https://doi.org/10.1016/S0140-6736(20)31304-0.

  78. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Med. 2008;5(3). https://doi.org/10.1371/journal.pmed.0050074.

  79. Keilman N. Erroneous Population Forecasts. In: Bengtsson T, Keilman N, editors. Old and New Perspectives on Mortality Forecasting. Cham: Springer; 2019.

    Google Scholar 

  80. Crèvecoeur J, Hens N, Neyens T, Larivière Y, Verhasselt B, Masson H. Change in COVID19 outbreak pattern following vaccination in long-term care facilities in Flanders, Belgium. Vaccine. 2022;40:6218–24.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The results reported herein correspond to specific aims of grant 682540-TransMID to investigator Niel Hens from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualisation: NH, PB, SM. Methodology: NH, PB, KN, SM. Data analysis and interpretation: NH, PB, KN, SM. Drafting the article: SM. Critical revision and approval of manuscript: NH, PB, KN, SM.

Corresponding author

Correspondence to Signe Møgelmose.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Møgelmose, S., Neels, K., Beutels, P. et al. Exploring the impact of population ageing on the spread of emerging respiratory infections and the associated burden of mortality. BMC Infect Dis 23, 767 (2023). https://doi.org/10.1186/s12879-023-08657-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08657-3

Keywords